Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentpostsynaptic density

NRG1 DISC1 SPTBN1 ADGRB1 ADGRB3 ADAM10 BMPR2 PTPRZ1 RNF10 KALRN GRM3 SHANK3 USP6 SORCS3 TANC1

9.73e-0545122115GO:0014069
GeneOntologyCellularComponentasymmetric synapse

NRG1 DISC1 SPTBN1 ADGRB1 ADGRB3 ADAM10 BMPR2 PTPRZ1 RNF10 KALRN GRM3 SHANK3 USP6 SORCS3 TANC1

1.80e-0447722115GO:0032279
GeneOntologyCellularComponentpostsynaptic specialization

NRG1 DISC1 SPTBN1 ADGRB1 ADGRB3 ADAM10 BMPR2 PTPRZ1 RNF10 KALRN GRM3 SHANK3 USP6 SORCS3 TANC1

3.17e-0450322115GO:0099572
GeneOntologyCellularComponentneuron to neuron synapse

NRG1 DISC1 SPTBN1 ADGRB1 ADGRB3 ADAM10 BMPR2 PTPRZ1 RNF10 KALRN GRM3 SHANK3 USP6 SORCS3 TANC1

4.76e-0452322115GO:0098984
GeneOntologyCellularComponentaxon

PCSK1 NRG1 MYCBP2 ADAM21 DISC1 SPTBN1 ADAM10 BMPR2 SACS PTPRZ1 SCN1A EXOC7 GOT1 CA2 ANK1 DCTN2 GRM3 AVIL UNC13C TANC1 CDH1

5.25e-0489122121GO:0030424
GeneOntologyCellularComponentcilium

CENPF PSG6 DISC1 SEPTIN9 SPEF2 KIF9 KCNU1 PKM AKT1 GNA11 DNAH8 ODAD3 DRC7 IFT74 SHANK3 EYS C2CD3 BBS7 MROH2B VCAN ROPN1

5.81e-0489822121GO:0005929
DomainCadherin

DCHS2 CDHR2 FAT1 PCDH19 FAT4 FREM3 CELSR1 CDH1 CDH5 CDH16

1.14e-0611821610IPR002126
DomainCadherin_CS

DCHS2 CDHR2 FAT1 PCDH19 FAT4 CELSR1 CDH1 CDH5 CDH16

4.91e-061092169IPR020894
DomainCADHERIN_1

DCHS2 CDHR2 FAT1 PCDH19 FAT4 CELSR1 CDH1 CDH5 CDH16

6.61e-061132169PS00232
DomainCadherin

DCHS2 CDHR2 FAT1 PCDH19 FAT4 CELSR1 CDH1 CDH5 CDH16

6.61e-061132169PF00028
DomainCADHERIN_2

DCHS2 CDHR2 FAT1 PCDH19 FAT4 CELSR1 CDH1 CDH5 CDH16

7.10e-061142169PS50268
Domain-

DCHS2 CDHR2 FAT1 PCDH19 FAT4 CELSR1 CDH1 CDH5 CDH16

7.10e-0611421692.60.40.60
DomainCA

DCHS2 CDHR2 FAT1 PCDH19 FAT4 CELSR1 CDH1 CDH5 CDH16

7.63e-061152169SM00112
DomainCadherin-like

DCHS2 CDHR2 FAT1 PCDH19 FAT4 CELSR1 CDH1 CDH5 CDH16

8.19e-061162169IPR015919
DomainXAP5

FAM50B FAM50A

1.33e-0422162IPR007005
DomainXAP5

FAM50B FAM50A

1.33e-0422162PF04921
DomainEGF-like_dom

NRG1 ADAM21 MATN2 FAT1 UMODL1 FAT4 NRG2 LAMC2 EYS CELSR1 VCAN

1.59e-0424921611IPR000742
DomainASX_HYDROXYL

MATN2 FAT1 UMODL1 FAT4 EYS CELSR1 VCAN

1.62e-041002167PS00010
DomainEGF-type_Asp/Asn_hydroxyl_site

MATN2 FAT1 UMODL1 FAT4 EYS CELSR1 VCAN

2.32e-041062167IPR000152
DomainGAIN_dom_N

ADGRB1 ADGRB3 CELSR1

2.35e-04112163IPR032471
DomainGAIN

ADGRB1 ADGRB3 CELSR1

2.35e-04112163PF16489
DomainEGF-like_CS

NRG1 ADAM21 MATN2 FAT1 UMODL1 FAT4 NRG2 LAMC2 EYS CELSR1 VCAN

2.39e-0426121611IPR013032
DomainEGF_2

NRG1 ADAM21 MATN2 FAT1 UMODL1 FAT4 NRG2 LAMC2 EYS CELSR1 VCAN

2.72e-0426521611PS01186
DomainHELICASE_CTER

ATRX TDRD9 HFM1 DDX31 HLTF SMARCA4 DHX32

2.76e-041092167PS51194
DomainHELICASE_ATP_BIND_1

ATRX TDRD9 HFM1 DDX31 HLTF SMARCA4 DHX32

2.76e-041092167PS51192
DomainHelicase_ATP-bd

ATRX TDRD9 HFM1 DDX31 HLTF SMARCA4 DHX32

2.92e-041102167IPR014001
DomainQuinoprotein_ADH-like_supfam

EML6 EML5 PCDH19 WDR36 WDSUB1

3.61e-04532165IPR011047
DomainGPCR_2_brain_angio_inhib

ADGRB1 ADGRB3

3.96e-0432162IPR008077
DomainNeuregulin_C

NRG1 NRG2

3.96e-0432162IPR002154
DomainNeuregulin

NRG1 NRG2

3.96e-0432162PF02158
DomainEGF

NRG1 MATN2 FAT1 UMODL1 FAT4 NRG2 LAMC2 EYS CELSR1 VCAN

4.24e-0423521610SM00181
DomainEGF_3

NRG1 ADAM21 MATN2 FAT1 UMODL1 FAT4 NRG2 EYS CELSR1 VCAN

4.24e-0423521610PS50026
Domain-

ETFDH FOXRED2 AIFM3 MTO1 SDHA

4.67e-045621653.50.50.60
DomainSPEC

SPTBN1 AKAP6 KALRN SYNE1

4.85e-04322164SM00150
DomainSpectrin/alpha-actinin

SPTBN1 AKAP6 KALRN SYNE1

4.85e-04322164IPR018159
DomainFAD/NAD-binding_dom

ETFDH FOXRED2 AIFM3 MTO1 SDHA

5.07e-04572165IPR023753
DomainEGF_CA

MATN2 FAT1 UMODL1 FAT4 EYS CELSR1 VCAN

5.47e-041222167SM00179
DomainEGF-like_Ca-bd_dom

MATN2 FAT1 UMODL1 FAT4 EYS CELSR1 VCAN

6.02e-041242167IPR001881
DomainEGF

NRG1 MATN2 FAT1 NRG2 EYS CELSR1 VCAN

6.63e-041262167PF00008
Domain-

NRG1 MYCBP2 HLA-DPA1 PSG6 MDGA2 PTPRJ UMODL1 PTPRZ1 CAMTA1 IL23R FNDC3B FLT1 KALRN NRG2 IGDCC3 PKHD1L1 VCAN CRTAM

7.25e-04663216182.60.40.10
DomainPyridine_nuc-diS_OxRdtase_2

ETFDH AIFM3

7.87e-0442162IPR000103
DomainEGF_1

NRG1 ADAM21 FAT1 UMODL1 FAT4 NRG2 LAMC2 EYS CELSR1 VCAN

7.98e-0425521610PS00022
DomainLAM_G_DOMAIN

FAT1 FAT4 EYS CELSR1

9.44e-04382164PS50025
DomainLaminin_G_2

FAT1 FAT4 EYS CELSR1

1.15e-03402164PF02210
DomainPyr_redox_2

ETFDH FOXRED2 AIFM3

1.29e-03192163PF07992
DomainIg-like_fold

NRG1 MYCBP2 HLA-DPA1 PSG6 MDGA2 PTPRJ UMODL1 PTPRZ1 CAMTA1 IL23R FNDC3B FLT1 KALRN NRG2 IGDCC3 PKHD1L1 VCAN CRTAM

1.47e-0370621618IPR013783
DomainApc4_WD40_dom

EML6 EML5 WDR36

1.50e-03202163IPR024977
DomainANAPC4_WD40

EML6 EML5 WDR36

1.50e-03202163PF12894
DomainHelicase_C

ATRX TDRD9 HFM1 DDX31 HLTF SMARCA4

1.53e-031072166PF00271
DomainHELICc

ATRX TDRD9 HFM1 DDX31 HLTF SMARCA4

1.53e-031072166SM00490
DomainCH

SPEF2 SPTBN1 NAV3 PLS1 SYNE1

1.57e-03732165PS50021
DomainHelicase_C

ATRX TDRD9 HFM1 DDX31 HLTF SMARCA4

1.60e-031082166IPR001650
DomainLamG

FAT1 FAT4 EYS CELSR1

1.64e-03442164SM00282
DomainDEXDc

ATRX TDRD9 HFM1 DDX31 HLTF SMARCA4

1.68e-031092166SM00487
DomainCH-domain

SPEF2 SPTBN1 NAV3 PLS1 SYNE1

1.77e-03752165IPR001715
DomainZnf_TFIIS

TCEA3 POLR2I

1.94e-0362162IPR001222
DomainAA_TRANSFER_CLASS_1

GOT1 ACCSL

1.94e-0362162PS00105
DomainHELP

EML6 EML5

1.94e-0362162PF03451
DomainTFIIS_C

TCEA3 POLR2I

1.94e-0362162PF01096
DomainZnF_C2C2

TCEA3 POLR2I

1.94e-0362162SM00440
DomainZF_TFIIS_1

TCEA3 POLR2I

1.94e-0362162PS00466
DomainZF_TFIIS_2

TCEA3 POLR2I

1.94e-0362162PS51133
DomainHELP

EML6 EML5

1.94e-0362162IPR005108
DomainP-loop_NTPase

ATRX TDRD9 ABCA12 SEPTIN9 SPEF2 GUF1 KIF9 NAV3 MFN2 HFM1 GNA11 CAMTA1 DNAH8 MPP7 DDX31 RFC3 HLTF SMARCA4 DHX32 DSEL

2.05e-0384821620IPR027417
DomainFN3

MDGA2 PTPRJ UMODL1 PTPRZ1 IL23R FNDC3B KALRN IGDCC3

2.26e-031992168PS50853
DomainSpectrin

SPTBN1 KALRN SYNE1

2.28e-03232163PF00435
DomainACTININ_2

SPTBN1 PLS1 SYNE1

2.28e-03232163PS00020
DomainACTININ_1

SPTBN1 PLS1 SYNE1

2.28e-03232163PS00019
DomainActinin_actin-bd_CS

SPTBN1 PLS1 SYNE1

2.28e-03232163IPR001589
DomainGrowth_fac_rcpt_

MATN2 FAT1 UMODL1 FAT4 LAMC2 EYS CELSR1

2.29e-031562167IPR009030
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DCHS2 ATRX MYCBP2 SPTBN1 DEF8 ADGRB3 SRPK2 FMNL2 BICD1 TTLL12 GUF1 SACS RNF10 NAV3 PKM EXOC7 SDHA AKAP6 ACTR8 KALRN IFT74 SYNE1 CACHD1 PRPF8 MIPOL1 PPP4R3B POLR3B APPL2 SMARCA4 ZNF76

1.11e-0912852233035914814
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

ATRX MYCBP2 ORC3 SRPK2 DNAJC10 MIOS MED27 DDX31 WDR36 MED16 POLR2I RFC3 PPP4R3B CEBPZ SMARCA4 NUP188 CDH1

4.65e-094402231734244565
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

ATRX RAPGEF5 SPTBN1 DEF8 FAM91A1 STX5 EML5 GNA11 CAMTA1 MTO1 COG5 TASOR AKAP6 WWP1 FAM171B E2F8 VCAN CDK5RAP2 NUP188 ACCSL PEAK1 CCDC171 CDH1

5.95e-0710842232311544199
Pubmed

Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

CENPF DISC1 SPTBN1 BICD1 EXOC7 AKAP6 KALRN DCTN2 SYNE1

6.25e-07151223917043677
Pubmed

Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.

PTPRJ FLT1 CDH5

1.04e-064223312771128
Pubmed

Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments.

PTPRJ FLT1 CDH5

1.04e-064223316893970
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

ATRX MYCBP2 RPN2 SPTBN1 FRS2 SRPK2 TTLL12 GUF1 STX5 DNAJC10 SACS GMDS SDHA MPP7 DDX31 WDR36 DCTN2 SYNE1 TUBA1C PRPF8 EXOC5 IARS2 CEBPZ BBS7 CDK5RAP2 TANC1 PEAK1

1.22e-0614872232733957083
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

NRG1 ATRX ORC3 SEPTIN9 SPTBN1 PSMD3 EXOC7 HNRNPLL DCTN2 TUBA1C RFC3 PRPF8 EXOC5 HLTF SMARCA4 USP39

1.31e-065822231620467437
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

ATRX ORC3 FAM91A1 SRPK2 GUF1 MIOS GNA11 MED27 TASOR TAF1L HNRNPLL WDR77 SDHA MPP7 FNDC3B DDX31 WDR36 MED16 SYNE1 TUBA1C POLR2I CELSR1 APPL2 CEBPZ SLC25A1 HLTF TANC1

1.38e-0614972232731527615
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

CENPF DISC1 SEPTIN9 ADGRB1 FRS2 FMNL2 TTLL12 MCM3AP PKM PLS1 SDHA FAT4 ANK1 IGDCC3 PRPF8 MIPOL1 NUP188 USP39

1.50e-067362231829676528
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

TPP2 RPN2 SPTBN1 PSMD3 LMBRD2 ADAM10 STX5 DNAJC10 EXOC7 COG5 WDR77 SDHA WDR36 DCTN2 TUBA1C RFC3 PRPF8 EXOC5 IARS2 POLR3B STRAP CEBPZ HLTF DHX32 NUP188 USP39

2.16e-0614402232630833792
Pubmed

CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.

MYCBP2 DISC1 FAM91A1 DNAJC10 MTO1 EXOC7 WDR77 TUBA1C RFC3 PPP4R3B EXOC5 IARS2 STRAP BBS7 HLTF DHX32

2.21e-066062231636538041
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

MYCBP2 CENPF PSMD3 SRPK2 DNAJC10 MIOS EXOC7 TASOR DDX31 WDR36 MED16 RFC3 PRPF8 EXOC5 POLR3B STRAP CEBPZ SMARCA4

2.30e-067592231835915203
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

RPN2 SPTBN1 PSMD3 ADAM10 FOXRED2 PTPRJ PKM WDR77 SDHA TUBA1C CACHD1 RFC3 PRPF8 STRAP SLC25A1 SMARCA4

2.56e-066132231622268729
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

TPP2 RPN2 SEPTIN9 SPTBN1 ADGRB3 PSMD3 SRPK2 FAM50B AP1M1 EXOC7 SDHA HSP90AA4P DCTN2 PRPF8 PPP4R3B POLR3B STRAP FAM50A SMARCA4

2.69e-068472231935235311
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

CDHR2 SPTBN1 S100A14 ACOT7 PSMD3 FAT1 EML5 PTPRJ PKM AP1M1 GNA11 PLS1 GOT1 C11orf52 CA2 KALRN DCTN2 EYS APPL2 SLC25A1 CDK5RAP2

2.84e-0610162232119056867
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

FRS2 FAM91A1 FMNL2 FAT1 STX5 PKM TASOR HNRNPLL FAT4 WDR36 TUBA1C FAM171B RFC3 PKHD1L1 IARS2 GCC2 CDK5RAP2 PEAK1

3.19e-067772231835844135
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

TPP2 CENPF SEPTIN9 ACOT7 PSMD3 PKM AP1M1 DNAH8 HNRNPLL RFC3 PRPF8 IARS2 POLR3B CEBPZ SLC25A1 SMARCA4 NUP188

3.49e-067042231729955894
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

ORC3 SEPTIN9 FAM91A1 PSMD3 AP1M1 EXOC7 COG5 SDHA WDR36 IFT74 TUBA1C PRPF8 EXOC5 POLR3B HLTF

3.88e-065602231535241646
Pubmed

Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation.

NRG1 AKT1 RLF VCAN SMARCA4

4.38e-0638223529743679
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

TPP2 SNX4 MYCBP2 RPN2 SPTBN1 FAM91A1 PSMD3 PTPN12 PTPRJ PTPRZ1 MIOS MPP7 DDX31 CACHD1 FAM171B PPP4R3B C2CD3 CEBPZ CDK5RAP2 TANC1 PEAK1

4.64e-0610492232127880917
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

ATRX RPN2 ORC3 FAM91A1 SRPK2 LMBRD2 TTLL12 LPIN1 DNAJC10 AP1M1 EXOC7 TASOR FNDC3B LAMC2 HLTF TANC1

5.36e-066502231638777146
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

ATRX CENPF RPN2 SPTBN1 PSMD3 TTLL12 PKM AP1M1 TDRD6 HNRNPLL WDR77 SDHA CA2 WDR36 SYNE1 TUBA1C RFC3 PRPF8 IARS2 STRAP CEBPZ SMARCA4 NUP188 USP39 PEAK1

5.66e-0614252232530948266
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

TPP2 MYCBP2 CENPF RPN2 SPTBN1 TTLL12 MCM3AP SDHA DDX31 WDR36 TUBA1C PRPF8 IARS2 CEBPZ SMARCA4 NUP188

5.68e-066532231622586326
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

TPP2 SEPTIN9 SPTBN1 ACOT7 PSMD3 SRPK2 FMNL2 SACS PTPRZ1 PKM MIOS SDHA GOT1 CA2 KALRN DCTN2 SYNE1 TUBA1C GRM3 SHANK3 APPL2 VCAN SMARCA4 TANC1 PEAK1

6.09e-0614312232537142655
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

FAM91A1 PSMD3 FMNL2 LPIN1 DNAJC10 MIOS WDR36 WWP1 TUBA1C FMNL3 IARS2

6.43e-063132231138270169
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

MYCBP2 RPN2 ADGRB1 PSMD3 SERPINB4 MIOS MPP7 CA2 WDR36 POLR2I RFC3 PRPF8 USP6 POLR3B GCC2 HLTF NUP188 USP39 ZNF639 WDTC1

8.61e-0610052232019615732
Pubmed

Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.

DCHS2 FAT1 FAT4

8.93e-067223316059920
Pubmed

Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.

PTPRZ1 AKT1 VCAN

8.93e-067223321976490
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

CENPF SPTBN1 EML6 FAT1 SACS DDX31 ANK1 LAMC2 PRPF8 EYS SMARCA4

1.12e-053322231137433992
Pubmed

RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.

RPN2 PSMD3 PKM AP1M1 WDR77 PLS1 SDHA DCTN2 STRAP SLC25A1 NUP188

1.55e-053442231136282215
Pubmed

Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool.

DCHS2 FAT1 FAT4 CDH1

1.58e-0524223426116661
Pubmed

Loss of Gata5 in mice leads to bicuspid aortic valve.

NRG1 TBX20 NOS3 CDH5

1.58e-0524223421633169
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

MYCBP2 SEPTIN9 SPTBN1 ADGRB1 ADGRB3 FAM91A1 PSMD3 SNRK STX5 SCN1A RNF10 NAV3 PKM AP1M1 HNRNPLL SDHA KALRN FAM171B SHANK3 OSBP PEAK1

1.60e-0511392232136417873
Pubmed

Endocardial Brg1 disruption illustrates the developmental origins of semilunar valve disease.

FRS2 BMPR2 VCAN SMARCA4

1.87e-0525223426100917
Pubmed

Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif.

MYCBP2 CENPF SPTBN1 BICD1

1.87e-0525223412522145
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

SEPTIN9 SPTBN1 FRS2 FAM91A1 FMNL2 BMPR2 STX5 PTPRJ PKM MPP7 FAM171B TANC1 PEAK1 CDH1

1.95e-055652231425468996
Pubmed

Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.

FAT4 CELSR1 CDH5

2.12e-059223328705793
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

CENPF RPN2 SEPTIN9 SPTBN1 PSMD3 SRPK2 PKM AP1M1 WDR77 SDHA WDR36 TUBA1C LAMC2 RFC3 PRPF8 IARS2 STRAP CEBPZ SLC25A1 SMARCA4 USP39 CDH1

2.21e-0512572232236526897
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

MYCBP2 SPTBN1 STRADB RNF10 PKM AKAP6 FNDC3B NRAP KALRN SYNE1 WWP1 APPL2 CDK5RAP2

2.22e-054972231323414517
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

MYCBP2 SEPTIN9 SPTBN1 ACOT7 PSMD3 GUF1 PTPN12 SERPINB4 MCM3AP PKM AP1M1 FNDC3B WDR36 GNE RFC3 PRPF8 RLF POLR3B CEBPZ SLC25A1 HLTF SMARCA4 TANC1

2.25e-0513532232329467282
Pubmed

Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.

NRG1 ABCA12 CAMTA1 MGAT4C PLS1 KALRN ASXL3

2.67e-05134223724324551
Pubmed

Proteomic analysis of murine Piwi proteins reveals a role for arginine methylation in specifying interaction with Tudor family members.

TDRD9 TDRD6 WDR77

3.02e-0510223319584108
Pubmed

Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin.

AKT1 NOS3 CDH5

3.02e-0510223327522498
Pubmed

A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB.

FAM91A1 FAT4 FLT1 UNC13C DSEL

3.60e-0558223519734545
Pubmed

ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.

RPN2 PSMD3 DNAJC10 PKM MIOS PLS1 SDHA GOT1 WWP1 TUBA1C OSBP USP39

3.90e-054512231236168627
Pubmed

CD148 tyrosine phosphatase promotes cadherin cell adhesion.

PTPRJ CDH1

4.09e-052223225386896
Pubmed

Endothelial nitric oxide synthase is involved in calcium-induced Akt signaling in mouse skeletal muscle.

AKT1 NOS3

4.09e-052223219682597
Pubmed

CAMTA1, a novel antitumor gene, regulates proliferation and the cell cycle in glioma by inhibiting AKT phosphorylation.

AKT1 CAMTA1

4.09e-052223233316386
Pubmed

Association of the DISC1 and NRG1 genetic polymorphisms with schizophrenia in a Chinese population.

NRG1 DISC1

4.09e-052223227236031
Pubmed

Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.

PEAK1 CDH1

4.09e-052223225445115
Pubmed

Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

VCAN CDH1

4.09e-052223223002209
Pubmed

Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway.

AKT1 NOS3

4.09e-052223218004295
Pubmed

Dravet syndrome and SCN1A gene mutation related-epilepsies: cognitive impairment and its determinants.

SCN1A PCDH19

4.09e-052223221504426
Pubmed

Membrane domain organization of myelinated axons requires βII spectrin.

SPTBN1 AVIL

4.09e-052223224217619
Pubmed

Regulation of arterial blood pressure by Akt1-dependent vascular relaxation.

AKT1 NOS3

4.09e-052223221842346
Pubmed

NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis.

NRG1 NRG2

4.09e-052223234996744
Pubmed

ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.

ADAM10 CDH5

4.09e-052223218420943
Pubmed

Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer.

AKT1 CDH1

4.09e-052223235705314
Pubmed

Kalirin: a novel genetic risk factor for ischemic stroke.

KALRN ROPN1

4.09e-052223220107840
Pubmed

The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.

NOS3 FLT1

4.09e-052223232215825
Pubmed

ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis.

ADAM10 CDH1

4.09e-052223218200054
Pubmed

Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.

SCN1A PCDH19

4.09e-052223233937968
Pubmed

E-cadherin enhances neuregulin signaling and promotes Schwann cell myelination.

NRG1 CDH1

4.09e-052223225988855
Pubmed

Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.

PTPN12 AIFM3

4.09e-052223231088422
Pubmed

A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.

ADAM10 FAT1

4.09e-052223224625754
Pubmed

Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway.

AKT1 NOS3

4.09e-052223224708830
Pubmed

Lipid-binding role of betaII-spectrin ankyrin-binding domain.

SPTBN1 ANK1

4.09e-052223217716929
Pubmed

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.

AKT1 NOS3

4.09e-052223210376603
Pubmed

Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway.

NOS3 SERPIND1

4.09e-052223222904320
Pubmed

Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells.

AIFM3 FMNL3

4.09e-052223234949658
Pubmed

Dravet syndrome: a genetic epileptic disorder.

SCN1A PCDH19

4.09e-052223223093055
Pubmed

Nitric oxide maintains endothelial redox homeostasis through PKM2 inhibition.

PKM NOS3

4.09e-052223231328803
Pubmed

Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial function.

AKT1 NOS3

4.09e-052223223384770
Pubmed

Erythropoietin increases endothelial biosynthesis of tetrahydrobiopterin by activation of protein kinase B alpha/Akt1.

AKT1 NOS3

4.09e-052223218519842
Pubmed

Pseudomonas aeruginosa Triggered Exosomal Release of ADAM10 Mediates Proteolytic Cleavage in Trans.

ADAM10 CDH1

4.09e-052223235163191
Pubmed

FMNL formins boost lamellipodial force generation.

FMNL2 FMNL3

4.09e-052223228327544
Pubmed

SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway.

SPTBN1 SOCS3

4.09e-052223232516133
Pubmed

Akt1 mediates purinergic-dependent NOS3 activation in thick ascending limbs.

AKT1 NOS3

4.09e-052223219570880
Pubmed

Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue.

SNRK AKT1

4.09e-052223231420304
Pubmed

Suppression of SCC antigen promotes cancer cell invasion and migration through the decrease in E-cadherin expression.

SERPINB4 CDH1

4.09e-052223217016656
Pubmed

The effects of alpha-secretase ADAM10 on the proteolysis of neuregulin-1.

NRG1 ADAM10

4.09e-052223219220854
Pubmed

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.

AKT1 NOS3

4.09e-052223211696579
Pubmed

Effects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway.

AKT1 NOS3

4.09e-052223222808143
Pubmed

The mitochondrial redistribution of ENOS is regulated by AKT1 and dimer status.

AKT1 NOS3

4.09e-052223239332480
Pubmed

Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.

NOS3 FLT1

4.09e-052223228115513
Pubmed

eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.

NOS3 FLT1

4.09e-052223222282588
Pubmed

AKT has an anti-apoptotic role in ABCA12-deficient keratinocytes.

ABCA12 AKT1

4.09e-052223221633372
Pubmed

Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.

NRG1 DISC1

4.09e-052223227613806
Pubmed

Human and mouse XAP-5 and XAP-5-like (X5L) genes: identification of an ancient functional retroposon differentially expressed in testis.

FAM50B FAM50A

4.09e-052223210534398
Pubmed

Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia.

NRG1 DISC1

4.09e-052223219913623
Pubmed

A strategy to identify protein-N-myristoylation-dependent phosphorylation reactions of cellular proteins by using Phos-tag SDS-PAGE.

FMNL2 FMNL3

4.09e-052223231751425
Pubmed

Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1.

AKT1 NOS3

4.09e-052223223255608
Pubmed

Progress in imaging the effects of psychosis susceptibility gene variants.

NRG1 DISC1

4.09e-052223223253390
Pubmed

Altered cytokine profile, pain sensitivity, and stress responsivity in mice with co-disruption of the developmental genes Neuregulin-1×DISC1.

NRG1 DISC1

4.09e-052223227916686
Pubmed

Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway.

AKT1 FLT1

4.09e-052223217311300
Pubmed

Brg1 inhibits E-cadherin expression in lung epithelial cells and disrupts epithelial integrity.

SMARCA4 CDH1

4.09e-052223228801844
Pubmed

Cocoa: a new mouse model for platelet storage pool deficiency.

CA2 HPS3

4.09e-05222323408670
Pubmed

Bowes melanoma cells secrete heregulin, which can promote aggregation and counteract invasion of human mammary cancer cells.

NRG1 CDH1

4.09e-052223215609326
Pubmed

Phosphorylation of Akt at Thr308 regulates p-eNOS Ser1177 during physiological conditions.

AKT1 NOS3

4.09e-052223233993653
InteractionSIRT6 interactions

ATRX MYCBP2 ORC3 SRPK2 FAT1 DNAJC10 MIOS AKT1 MED27 FAT4 DDX31 WDR36 MED16 POLR2I RFC3 PRPF8 HPS3 PPP4R3B CELSR1 CEBPZ SMARCA4 NUP188 CDH1

3.63e-0762821823int:SIRT6
InteractionANK2 interactions

ATRX MYCBP2 RAPGEF5 SPTBN1 ACOT7 ADAM10 KALRN SHANK3

1.13e-05982188int:ANK2
InteractionDSCAM interactions

ATRX SPTBN1 BICD1 GUF1 SACS SDHA KALRN SYNE1 PRPF8 POLR3B

1.77e-0517121810int:DSCAM
InteractionNANS interactions

BICD1 PTPRJ PKM GOT1 PPP4R3B IARS2 CDH1 WDTC1

2.46e-051092188int:NANS
InteractionLAG3 interactions

HLA-DPA1 FAT1 CELSR1 CEBPZ

2.84e-05172184int:LAG3
InteractionSHANK3 interactions

SPTBN1 ACOT7 PSMD3 ADAM10 PKM EXOC7 SDHA GOT1 KALRN DCTN2 SYNE1 WWP1 TUBA1C GRM3 SHANK3 MIPOL1 SLC25A1

3.02e-0549621817int:SHANK3
InteractionCDC42 interactions

RPN2 SEPTIN9 SPTBN1 FRS2 ACOT7 FAM91A1 PSMD3 FMNL2 BMPR2 FAT1 STX5 DNAJC10 PTPRJ MCM3AP FGD1 GNA11 COG5 SDHA MPP7 FNDC3B FAT4 SYNE1 TUBA1C RFX6 RFC3 FMNL3 USP6 CEBPZ SLC25A1 PEAK1 CDH1

3.96e-05132321831int:CDC42
InteractionSVIL interactions

ATRX MYCBP2 CENPF DISC1 SEPTIN9 SPTBN1 PKM WDR77 FLT1 AVIL CDH1

4.91e-0523321811int:SVIL
InteractionNXF1 interactions

TPP2 ZNF142 DISC1 SPTBN1 ETFDH PSMD3 SRPK2 MCM3AP RNF10 MFN2 EXOC7 TAF1L SDHA GOT1 FAT4 WDR36 DCTN2 ANKRD10 SETD4 PRPF8 HPS3 OSBP POLR3B STRAP CEBPZ FAM50A HLTF ZNF76 TANC1 NUP188 WDTC1

5.40e-05134521831int:NXF1
InteractionMAGEA6 interactions

SNX4 S100A14 ACOT7 STX5 MIPOL1 EXOC5 ZNF76

5.50e-05902187int:MAGEA6
GeneFamilyCadherin related

DCHS2 CDHR2 FAT1 FAT4

7.37e-0617139424
GeneFamilyAdhesion G protein-coupled receptors, subfamily B

ADGRB1 ADGRB3

1.75e-0431392912
GeneFamilyWD repeat domain containing

EML6 EML5 WDR77 WDR36 MED16 STRAP WDSUB1 WDTC1

9.61e-042621398362
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

NRG1 MDGA2 FLT1 KALRN NRG2 IGDCC3

1.54e-031611396593
GeneFamilyExocyst complex

EXOC7 EXOC5

2.04e-03913921055
GeneFamilySerpin peptidase inhibitors

SERPINI2 SERPINB4 SERPIND1

2.85e-03371393739
GeneFamilyMaestro heat like repeat containing

MROH7 MROH2B

3.08e-03111392636
GeneFamilyX-linked mental retardation|RNA helicases

ATRX HFM1

3.08e-031113921168
GeneFamilyTHAP domain containing

THAP5 THAP9

3.68e-0312139265
CoexpressionGSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP

ATRX MYCBP2 SEPTIN9 SPTBN1 DDX31 GNE POLR2I PELI2 HPS3 APPL2 HLTF CDH1

1.46e-0720022112M8644
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

NRG1 SNX4 ATRX MYCBP2 CENPF SEPTIN9 SRPK2 ADAM10 BICD1 FAT1 PTPN12 SACS NAV3 COG5 TASOR GNE WWP1 RLF USP6 C2CD3 ELL2 GCC2 HLTF

1.09e-0685622123M4500
CoexpressionLAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES

SPTBN1 FMNL2 BMPR2 HIBCH FLT1 KALRN SYNE1 SHANK3 PEAK1

2.58e-061372219M39241
CoexpressionAIZARANI_LIVER_C20_LSECS_3

BDP1 RAPGEF5 SNRK BMPR2 NOS3 FNDC3B FLT1 SOCS3 SHANK3 TANC1 PEAK1 CDH5

8.56e-0629522112M39121
CoexpressionGSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN

SPEF2 EML5 PTPRZ1 IL23R WWP1 SOCS3 APPL2 TANC1 CDH5

2.25e-051792219M6689
CoexpressionERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP

THAP5 BDP1 TPP2 DNAJC10 HIBCH SACS MTO1 TASOR WWP1 TMEM161B PRELID3B PPP4R3B EXOC5 ELL2 CEBPZ CRTAM HLTF ZNF639

2.35e-0568722118M41022
CoexpressionGSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN

HLA-DPA1 BICD1 CAMTA1 HNRNPLL BATF SYNE1 CCDC92 ZNF335 CDH1

4.95e-051982219M6511
CoexpressionGSE14308_TH17_VS_INDUCED_TREG_UP

ATRX MYCBP2 SPEF2 SACS PKM TBX20 DNAH8 CCDC92 EXOC5

5.35e-052002219M3385
CoexpressionGSE21379_WT_VS_SAP_KO_CD4_TCELL_UP

ACOT7 PTPN12 GMDS NOS3 C11orf52 FAM50A CDK5RAP2 TANC1 CDH5

5.35e-052002219M7499
CoexpressionGSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN

PSMD3 TTLL12 ACTR8 WDR36 IFT74 PRELID3B GLCE USP39 WDSUB1

5.35e-052002219M6020
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

CENPF ADGRB3 MDGA2 FMNL2 BICD1 EML5 PTPRZ1 PCDH19 TMEM161B IGDCC3 FAM171B APPL2 CEBPZ SLC25A1 DHX32 CCDC171

2.73e-0732821616Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5

BDP1 CENPF MDGA2 BICD1 EML5 PTPRZ1 PCDH19 IGDCC3 FAM171B SLC25A1 DHX32

2.72e-0523221611Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
ToppCellRA-10._Endothelium_II|World / Chamber and Cluster_Paper

NRG1 RAPGEF5 SPTBN1 BMPR2 PTPN12 HIBCH GMDS NOS3 FLT1 PELI2 PKHD1L1 SHANK3 VCAN

1.24e-111892201375c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SYNE1 SHANK3 FMNL3 PEAK1 CDH5

1.72e-1119422013a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SYNE1 SOCS3 SHANK3 FMNL3 CDH5

2.23e-111982201331ba87552be97c9b78c9e82f98e96699ccb19824
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SOCS3 SHANK3 FMNL3 PEAK1 CDH5

2.23e-11198220130a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SHANK3 FMNL3 PEAK1 CDH5

3.17e-1019722012cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SHANK3 FMNL3 PEAK1 CDH5

3.17e-1019722012412cb5f37df57121ddd1492021445479c7cbccbf
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 MDGA2 FAT1 NRK NAV3 FAT4 ANK1 KALRN PKHD1L1 ASXL3 UNC13C

2.15e-09184220112cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 MDGA2 FAT1 NRK NAV3 FAT4 ANK1 KALRN PKHD1L1 ASXL3 UNC13C

2.15e-09184220112b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 MDGA2 FAT1 NRK NAV3 FAT4 ANK1 KALRN PKHD1L1 ASXL3 UNC13C

2.15e-0918422011ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCelldroplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATRX RAPGEF5 SPTBN1 BMPR2 SACS NRK NOS3 FLT1 PKHD1L1 TANC1 CDH5

2.40e-09186220110ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCellRA-10._Endothelium_II|RA / Chamber and Cluster_Paper

NRG1 RAPGEF5 SPTBN1 BMPR2 PTPN12 HIBCH GMDS FLT1 PELI2 PKHD1L1 SHANK3

2.84e-0918922011c81787a8c662db5d7814c583dd64562857629e81
ToppCellRV-10._Endothelium_II|World / Chamber and Cluster_Paper

NRG1 RAPGEF5 SPTBN1 BMPR2 PTPN12 HIBCH GMDS FLT1 PELI2 PKHD1L1 SHANK3

3.54e-09193220112531266bc57339d4e2b22a88817008e32b8c1598
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NOS3 FLT1 KALRN SHANK3 FMNL3 PEAK1 CDH5

3.74e-0919422011f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NOS3 FLT1 KALRN SHANK3 FMNL3 PEAK1 CDH5

3.74e-0919422011f76808666fb875fc787751cbfd924d9be20a8192
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 SPEF2 SNRK SRPK2 BICD1 BMPR2 FAT4 FLT1 CACHD1 SHANK3 CDH5

3.74e-09194220110b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

RAPGEF5 MATN2 SNRK BMPR2 NOS3 FAT4 FLT1 SOCS3 FAM171B SHANK3 CDH5

4.16e-091962201114dd6956ef420b660be0baf52a66960e57d75d16
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SHANK3 FMNL3 PEAK1 CDH5

4.16e-0919622011ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

4.63e-0919822011fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NAV3 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

4.63e-091982201107701c73137947ed4a27e225975329235bbb8734
ToppCellCOPD-Epithelial-Basal|World / Disease state, Lineage and Cell class

NRG1 FAT1 SERPINB4 OVCH2 LAMC2 CAMK1G CACHD1 CELSR1 TANC1 CDH1

2.48e-08181220106d8a886b4afe729f8a05b9c0f4ea9375de735da4
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DCHS2 EFCAB13 MDGA2 BICD1 FAT1 NAV3 MGAT4C VWA3A SYNE1 VCAN

2.48e-08181220105f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DCHS2 EFCAB13 MDGA2 BICD1 FAT1 NAV3 MGAT4C VWA3A SYNE1 VCAN

2.48e-0818122010c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCellControl-Epithelial-Basal|World / Disease state, Lineage and Cell class

NRG1 S100A14 FAT1 PTPRZ1 SERPINB4 LAMC2 CACHD1 CELSR1 ASXL3 CDH1

2.62e-0818222010759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCellCOPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class

S100A14 FAT1 SERPINB4 OVCH2 LAMC2 CAMK1G CACHD1 CELSR1 TANC1 CDH1

2.76e-08183220100f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCellCOVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type

RAPGEF5 ADGRB3 NAV3 NOS3 FLT1 KALRN SYNE1 SHANK3 FMNL3 CDH5

2.76e-08183220103c4153479fc4ab2d073d92cee120480015555914
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 NAV3 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

3.38e-081872201035c382c0aabd46906113e5db30ea24bb8e658899
ToppCellCOVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type

NRG1 RAPGEF5 MATN2 GMDS NOS3 FLT1 PELI2 PKHD1L1 SHANK3 UNC13C

3.74e-08189220107346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCellRV-10._Endothelium_II|RV / Chamber and Cluster_Paper

NRG1 RAPGEF5 BMPR2 PTPN12 HIBCH GMDS FLT1 PELI2 PKHD1L1 SHANK3

4.56e-081932201001c2df9206f1527c578e808978e58196c35e72f5
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 SPEF2 SNRK SRPK2 BICD1 FAT4 FLT1 CACHD1 SHANK3 CDH5

4.56e-08193220106e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SPTBN1 ADGRB3 BMPR2 NAV3 FLT1 CACHD1 SHANK3 FMNL3 PEAK1 CDH5

4.78e-081942201074a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

5.27e-08196220108ad8efb631164b46f0c082572270188e5ead20bf
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SPTBN1 ADGRB3 BMPR2 NAV3 FLT1 KALRN CACHD1 PKHD1L1 SHANK3 CDH5

5.27e-081962201022767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 BMPR2 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

5.27e-08196220109606ea7e42f707e69ea891b3521037613b9675f5
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SPTBN1 ADGRB3 BMPR2 NAV3 FLT1 KALRN CACHD1 PKHD1L1 SHANK3 CDH5

5.27e-0819622010adee900dcd16dbaba15c58bdcace09ba20214950
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 NAV3 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

5.53e-08197220100f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 NOS3 FLT1 KALRN SYNE1 SHANK3 FMNL3 CDH5

5.80e-0819822010440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 NOS3 FLT1 KALRN SYNE1 SHANK3 FMNL3 CDH5

5.80e-0819822010451003a21162eeae90739fdb502bb50b362d80c8
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ATRX RAPGEF5 SPEF2 SPTBN1 SNRK BMPR2 NOS3 FAT4 FLT1 CDH5

6.37e-0820022010a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 ADGRB3 FMNL2 NOS3 FLT1 SYNE1 PKHD1L1 SHANK3 CDH5

2.00e-071722209c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RAPGEF5 SPTBN1 NAV3 MGAT4C KALRN PKHD1L1 SHANK3 PEAK1 CDH5

2.67e-071782209ad3de3e03a401dac64431a541899445262246347
ToppCellControl-Epithelial-Basal|Control / Disease state, Lineage and Cell class

S100A14 FAT1 PTPRZ1 SERPINB4 LAMC2 CACHD1 CELSR1 ASXL3 CDH1

3.22e-071822209caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCellCOVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

RAPGEF5 SPTBN1 ADAM10 MGAT4C MPP7 KALRN PKHD1L1 SHANK3 CDH5

3.70e-0718522094a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCellCOVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

RAPGEF5 SPTBN1 ADAM10 MGAT4C MPP7 KALRN PKHD1L1 SHANK3 CDH5

3.70e-07185220936ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RAPGEF5 SPTBN1 NAV3 MGAT4C KALRN PKHD1L1 SHANK3 PEAK1 CDH5

3.87e-07186220920340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCellCOVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

RAPGEF5 SPTBN1 NOS3 FLT1 KALRN SYNE1 SHANK3 PEAK1 CDH5

4.43e-071892209fe49852ba15f948b384d6b4c258927c70b741357
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

RAPGEF5 SPTBN1 BMPR2 FLT1 KALRN SYNE1 SHANK3 TANC1 CDH5

4.43e-071892209b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCHS2 SPTBN1 BMPR2 FLT1 KALRN SYNE1 SHANK3 TANC1 CDH5

4.63e-0719022090a351609a72fd638c84b2435782e312ee6a33aac
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPTBN1 BMPR2 FAT4 FLT1 KALRN SYNE1 SHANK3 TANC1 CDH5

4.63e-0719022090e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATRX SPTBN1 ADAM10 TASOR MGAT4C WWP1 PPP4R3B B4GALNT2 CDH1

4.84e-07191220960c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATRX SPTBN1 ADAM10 TASOR MGAT4C WWP1 PPP4R3B B4GALNT2 CDH1

4.84e-07191220909db184cb90fe282a14474d7217068c58092c6f8
ToppCellLPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 SPTBN1 SNRK BMPR2 FLT1 CACHD1 FMNL3 TANC1 CDH5

4.84e-071912209a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPTBN1 BMPR2 FAT4 FLT1 KALRN SYNE1 SHANK3 TANC1 CDH5

4.84e-071912209f229abf69a1217194f74b0502486907e07dba989
ToppCellRA-09._Endothelium_I|World / Chamber and Cluster_Paper

RAPGEF5 BMPR2 NOS3 FLT1 KALRN SYNE1 PKHD1L1 SHANK3 CDH5

4.84e-071912209c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATRX SPTBN1 ADAM10 TASOR MGAT4C WWP1 PPP4R3B B4GALNT2 CDH1

4.84e-071912209973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellCOVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type

NRG1 RAPGEF5 MATN2 HIBCH GMDS PELI2 PKHD1L1 VCAN UNC13C

5.06e-071922209c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCellRA-09._Endothelium_I|RA / Chamber and Cluster_Paper

RAPGEF5 BMPR2 NOS3 FLT1 KALRN SYNE1 PKHD1L1 SHANK3 CDH5

5.06e-0719222098a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCellIPF-Epithelial-Basal|World / Disease state, Lineage and Cell class

S100A14 FAT1 PTPRZ1 SERPINB4 LAMC2 CACHD1 CELSR1 TANC1 CDH1

5.06e-0719222099b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCellIPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class

RAPGEF5 SPTBN1 MGAT4C KALRN FAM171B PKHD1L1 SHANK3 TANC1 CDH5

5.06e-0719222092496edd8f3a41146d418879de9ee2ccc7857431f
ToppCellLPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 DISC1 SPEF2 SNRK FAT4 FLT1 CACHD1 SHANK3 CDH5

5.28e-071932209af5108260783e69a7d67896c5bf64f862525926d
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 SPEF2 SNRK SRPK2 BICD1 FAT4 FLT1 SHANK3 CDH5

5.28e-071932209e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCellCOVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

RAPGEF5 SPTBN1 SNRK FLT1 KALRN SYNE1 SHANK3 TANC1 CDH5

5.28e-071932209979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 PTPN12 FAT4 FLT1 SYNE1 PKHD1L1 SHANK3 CDH5

5.28e-071932209456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HLA-DPA1 ADGRB3 SNRK NOS3 FLT1 KALRN PKHD1L1 SHANK3 CDH5

5.51e-071942209cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21
ToppCellLPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 SNRK BMPR2 FAT4 FLT1 CACHD1 SHANK3 TANC1 CDH5

5.51e-07194220958f069efdefa0366033764446b9d6ffd4a17807e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 ADGRB3 FMNL2 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

5.51e-071942209b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCellLV-10._Endothelium_II|LV / Chamber and Cluster_Paper

NRG1 RAPGEF5 BMPR2 GMDS NOS3 FLT1 PELI2 PKHD1L1 SHANK3

5.51e-071942209b6cc849fa08599bff9839ef382d190cc964e273e
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 FMNL2 FLT1 SYNE1 PKHD1L1 SHANK3 CDH5

5.51e-071942209ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCellLPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 SNRK BMPR2 FAT4 FLT1 CACHD1 SHANK3 TANC1 CDH5

5.51e-071942209bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 ADGRB3 BMPR2 NAV3 FLT1 KALRN SHANK3 FMNL3 CDH5

5.51e-071942209e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADGRB3 SNRK BMPR2 NOS3 FLT1 KALRN SOCS3 SHANK3 CDH5

5.76e-071952209818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

6.01e-071962209b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

6.01e-071962209145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCellASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

MATN2 SNRK BMPR2 NOS3 FAT4 FLT1 SOCS3 SHANK3 CDH5

6.01e-0719622092b777a2026b56839112fd179f2db482c49f4594a
ToppCellCOVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type

RAPGEF5 SPTBN1 SNRK BMPR2 FLT1 KALRN SYNE1 SHANK3 CDH5

6.01e-07196220949cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCellCOVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type

RAPGEF5 SPTBN1 SNRK BMPR2 FLT1 KALRN SYNE1 SHANK3 CDH5

6.01e-0719622094ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 NOS3 FLT1 KALRN SHANK3 FMNL3 CDH5

6.01e-071962209d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCellnucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

RAPGEF5 SPTBN1 BMPR2 FLT1 KALRN PKHD1L1 SHANK3 TANC1 CDH5

6.27e-071972209ebf9be068eaa658493fa7884fd19f34642922acb
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 ADGRB3 FLT1 KALRN SYNE1 SHANK3 FMNL3 CDH5

6.54e-0719822091378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCellASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

RAPGEF5 SPTBN1 SNRK BMPR2 NOS3 FLT1 SOCS3 SHANK3 CDH5

6.54e-071982209e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RAPGEF5 SPTBN1 SNRK BICD1 BMPR2 FAT4 FLT1 SHANK3 CDH5

6.54e-071982209d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCellASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

RAPGEF5 SPTBN1 SNRK BMPR2 NOS3 FLT1 SOCS3 SHANK3 CDH5

6.82e-0719922090bc97a9a78aaafd1554ae6a61356ed9ea4983fa5
ToppCellTracheal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

HLA-DPA1 RAPGEF5 SPTBN1 BMPR2 NOS3 FLT1 SOCS3 SHANK3 CDH5

7.11e-07200220971ba0e48ca4ded077f2b96a0cf4f2331f2e25d15
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ATRX RAPGEF5 SPEF2 SPTBN1 SNRK BMPR2 FAT4 FLT1 CDH5

7.11e-072002209dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellTracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

HLA-DPA1 RAPGEF5 SPTBN1 BMPR2 NOS3 FLT1 SOCS3 SHANK3 CDH5

7.11e-07200220906ffa5baad3e699cf66d8b2c7513649e1d2c7e62
ToppCellAdult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor

UMODL1 NOS3 FLT1 SMCO3 KALRN PKHD1L1 SHANK3 SUN3

1.36e-0616022080cfe130606af433b2aa90e0a20b6c44659dd6fd4
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 SPTBN1 KCNU1 FLT1 SYNE1 PKHD1L1 SHANK3 TANC1

2.04e-061692208987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor

ABCA12 SPTBN1 NRK FLT1 KALRN SYNE1 SHANK3 CDH5

2.23e-061712208bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SPTBN1 ADGRB3 NAV3 FLT1 KALRN CACHD1 SHANK3 CDH5

3.14e-0617922088f9e538c822940785130297712b75131812a4603
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZSCAN12 CENPF RAPGEF5 BICD1 FLT1 TUBA1C SOCS3 SHANK3

3.14e-061792208327cc39161741ddbc4e8d45b9b3d30b3ce508929
ToppCelldroplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAPGEF5 BMPR2 SACS NAV3 FLT1 TANC1 PEAK1 CDH5

3.40e-06181220892d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RAPGEF5 NAV3 MGAT4C KALRN PKHD1L1 SHANK3 PEAK1 CDH5

3.40e-061812208e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

RAPGEF5 SPTBN1 BMPR2 FLT1 KALRN SYNE1 SHANK3 CDH5

3.40e-061812208c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DCHS2 RAPGEF5 SPTBN1 BMPR2 FLT1 KALRN SHANK3 CDH5

3.55e-061822208a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor

RAPGEF5 SPTBN1 BMPR2 NRK FLT1 KALRN SHANK3 CDH5

3.55e-0618222088b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RAPGEF5 SPTBN1 NAV3 MGAT4C KALRN PKHD1L1 SHANK3 CDH5

3.69e-0618322084d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCellControl-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations)

BMPR2 NAV3 NOS3 FLT1 KALRN PKHD1L1 SHANK3 CDH5

3.69e-06183220846be9f96755c7b65aeac061d95d15abeb6466034
ToppCellCOVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

RAPGEF5 SPTBN1 SNRK FMNL2 FLT1 KALRN SHANK3 ELL2

4.00e-061852208673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCellControl-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class

RAPGEF5 SPTBN1 FLT1 KALRN SYNE1 SHANK3 TANC1 CDH5

4.00e-061852208a28187c2fd23564314b35759479ff2ca21f61485
ToppCellCOVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

RAPGEF5 BMPR2 NOS3 FLT1 KALRN PKHD1L1 SHANK3 CDH5

4.33e-0618722082d20193a6cacdfa4877457c97b0077408942186c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RAPGEF5 ADGRB3 MDGA2 KALRN SYNE1 CAMK1G GRM3 ELL2

4.33e-06187220815d6e158562d7d85af3ceaf955439b379c8fce81
DiseaseColorectal Carcinoma

ABCA12 ETFDH IPP LPIN1 FAT1 SACS MCM3AP AKT1 DNAH8 AKAP6 KALRN SYNE1 SETD4 HPS3 OSBP STRAP B4GALNT2 DSEL CDH1 CDH5

2.69e-0770221620C0009402
Diseasebipolar disorder (is_implicated_in)

NRG1 DISC1 AKT1 SYNE1

5.75e-05292164DOID:3312 (is_implicated_in)
DiseaseCharcot-Marie-Tooth disease (is_implicated_in)

NRG1 MFN2 POLR3B

8.11e-05122163DOID:10595 (is_implicated_in)
Diseaseinternet addiction disorder

NRG1 DISC1 ANK1 GRM3

9.67e-05332164EFO_0803368
Diseasecardiomyopathy (biomarker_via_orthology)

ADAM10 NOS3 GOT1

1.05e-04132163DOID:0050700 (biomarker_via_orthology)
DiseaseMalignant neoplasm of breast

NRG1 CENPF EFCAB13 ADAM10 BMPR2 STX5 MROH7 AP1M1 AKT1 NOS3 AKAP6 FNDC3B FLT1 ANK1 KALRN SYNE1 MOSPD1 DHX32 CDH1 CDH5

1.34e-04107421620C0006142
Diseasepsychotic disorder (is_implicated_in)

NRG1 DISC1

1.59e-0432162DOID:2468 (is_implicated_in)
Diseaseneutrophil gelatinase-associated lipocalin measurement

PSMD3 ELL2

1.59e-0432162EFO_0021964
Diseaseacute graft vs. host disease, donor genotype effect measurement

MDGA2 KALRN EYS

1.65e-04152163EFO_0004599, EFO_0007892
DiseaseSchizophrenia

NRG1 DISC1 SHANK3

2.91e-04182163cv:C0036341
Diseasediabetic retinopathy (biomarker_via_orthology)

MFN2 AKT1 NOS3 FLT1

3.29e-04452164DOID:8947 (biomarker_via_orthology)
DiseaseHereditary Non-Polyposis Colon Cancer Type 2

PTPRJ SMARCA4 CDH1

3.44e-04192163C1333991
DiseaseColorectal cancer, hereditary nonpolyposis, type 1

PTPRJ SMARCA4 CDH1

3.44e-04192163C2936783
DiseaseQRS duration

NRG1 PTPRJ TBX20 COG5 MGAT4C PLS1 TCEA3 FAT4 FMNL3

3.74e-042982169EFO_0005055
DiseaseAlzheimer disease, dementia, family history of Alzheimer’s disease

EML6 HNRNPLL FMNL3 POLR3B

4.22e-04482164EFO_0009268, MONDO_0001627, MONDO_0004975
DiseaseIntellectual Disability

ZNF142 DISC1 SACS SCN1A CA2 AKAP6 SYNE1 SHANK3 POLR3B BBS7 ZNF335

4.92e-0444721611C3714756
Diseasemalignant astrocytoma (is_marker_for)

ATRX ADGRB1 AKT1

6.15e-04232163DOID:3069 (is_marker_for)
Diseaseretinitis pigmentosa

DNAJC10 EYS

7.85e-0462162MONDO_0019200
DiseaseHereditary Nonpolyposis Colorectal Neoplasms

PTPRJ SMARCA4 CDH1

8.88e-04262163C0009405
DiseaseColorectal cancer

PTPN12 PTPRJ AKT1

9.94e-04272163cv:C0346629
DiseaseNeoplasm of the large intestine

PTPN12 PTPRJ AKT1

9.94e-04272163cv:C0009404
DiseaseCOLORECTAL CANCER

PTPN12 PTPRJ AKT1

9.94e-04272163114500
DiseaseHereditary non-polyposis colorectal cancer syndrome

PTPRJ SMARCA4 CDH1

9.94e-04272163C1112155
DiseaseColorectal Neoplasms

ABCA12 IPP FAT1 AKT1 SYNE1 STRAP CDH1 CDH5

1.05e-032772168C0009404
DiseaseOvarian neoplasm

AKT1 CDH1

1.09e-0372162cv:C0919267
DiseaseHelicobacter Infections

PTPRZ1 CDH1

1.09e-0372162C0079487
Diseaselung small cell carcinoma (is_implicated_in)

ATRX FAT1 LAMC2

1.11e-03282163DOID:5409 (is_implicated_in)
DiseasePR interval

MYCBP2 ABCA12 SPTBN1 BMPR2 FAT1 HFM1 CAMTA1 TBX20 AKAP6 FNDC3B KALRN

1.13e-0349521611EFO_0004462
DiseaseHereditary Nonpolyposis Colorectal Cancer

PTPRJ SMARCA4 CDH1

1.23e-03292163C1333990
DiseaseMental Retardation, X-Linked

ATRX PCDH19 FGD1

1.23e-03292163C1136249
DiseaseOvarian Carcinoma

AKT1 SMARCA4 CDH1

1.36e-03302163C0029925
Diseasepulmonary hypertension (is_implicated_in)

BMPR2 NOS3 IL23R

1.36e-03302163DOID:6432 (is_implicated_in)
Diseaseasthma

HLA-DPA1 SPEF2 PSMD3 FMNL2 SUOX MROH7 TASOR SEMG2 WDR36 SOCS3 GRM3 CDK5RAP2 ZNF76 UNC13C

1.36e-0375121614MONDO_0004979
Diseasememory impairment

FAT4 SHANK3

1.45e-0382162EFO_0001072
Diseaseschizophrenia (implicated_via_orthology)

NRG1 DISC1 AKT1 SHANK3

1.58e-03682164DOID:5419 (implicated_via_orthology)
Diseaseretinal degeneration (implicated_via_orthology)

NOS3 DCTN2 EYS

1.79e-03332163DOID:8466 (implicated_via_orthology)
DiseaseColon Carcinoma

PTPN12 PTPRJ

1.86e-0392162C0699790
Diseaseelectrocardiography

NRG1 MYCBP2 HLA-DPA1 SPTBN1 PTPN12 RNF10 TBX20 COG5 TCEA3 FNDC3B FMNL3

1.93e-0353021611EFO_0004327
Diseasecolorectal cancer (is_implicated_in)

SEPTIN9 FAT1 PTPN12 PTPRJ AKT1

2.01e-031212165DOID:9256 (is_implicated_in)
Diseaseplacenta growth factor measurement

RAPGEF5 FLT1

2.81e-03112162EFO_0010626
Diseasecorpus callosum anterior volume measurement

NAV3 LAMC2 FAM171B

2.91e-03392163EFO_0010295
Diseaserefractive error, age at onset, Myopia

TDRD9 AKAP6 FNDC3B FLT1 GRM3 B4GALNT2

3.07e-031932166EFO_0004847, HP_0000545, MONDO_0004892
DiseaseEpilepsy, Cryptogenic

SCN1A PCDH19 AKT1 ASXL3

3.13e-03822164C0086237
DiseaseAwakening Epilepsy

SCN1A PCDH19 AKT1 ASXL3

3.13e-03822164C0751111
DiseaseCardiomegaly

MFN2 AKT1 TBX20 NOS3

3.13e-03822164C0018800
DiseaseAura

SCN1A PCDH19 AKT1 ASXL3

3.13e-03822164C0236018
DiseaseCardiac Hypertrophy

MFN2 AKT1 TBX20 NOS3

3.13e-03822164C1383860
Diseaseinvasive ductal carcinoma (is_marker_for)

ADGRB1 FGD1 SOCS3

3.13e-03402163DOID:3008 (is_marker_for)
Diseasethyroid gland carcinoma (is_marker_for)

FLT1 CDH5

3.35e-03122162DOID:3963 (is_marker_for)
Diseaseoncostatin-M measurement

PSMD3 MED16

3.35e-03122162EFO_0010792
DiseaseSecondary Open Angle Glaucoma

FNDC3B WDR36

3.35e-03122162C0271148
DiseaseGlaucoma, Open-Angle

FNDC3B WDR36

3.35e-03122162C0017612
Diseaseneuropsychological test

FAM91A1 FAT4 FLT1 POLR3B UNC13C DSEL

3.39e-031972166EFO_0003926
DiseaseAntihypertensive use measurement

SEPTIN9 ETFDH GMDS NOS3 GLCE SORCS3 CDH16

3.51e-032652167EFO_0009927
DiseaseCharcot-Marie-Tooth disease

MCM3AP MFN2 DCTN2

3.60e-03422163cv:C0007959
DiseaseProfound Mental Retardation

DISC1 SCN1A SHANK3 POLR3B BBS7

3.65e-031392165C0020796
DiseaseMental deficiency

DISC1 SCN1A SHANK3 POLR3B BBS7

3.65e-031392165C0917816
DiseaseMental Retardation, Psychosocial

DISC1 SCN1A SHANK3 POLR3B BBS7

3.65e-031392165C0025363
Diseasepeak expiratory flow

SRPK2 GMDS TBX20 FNDC3B FREM3 EYS BBS7 GLCE ZNF76 CCDC171

3.87e-0349821610EFO_0009718
DiseaseInfantile Severe Myoclonic Epilepsy

SCN1A PCDH19

3.95e-03132162C0751122
DiseaseGlaucoma, Primary Open Angle

FNDC3B WDR36

3.95e-03132162C0339573
Diseasecognitive impairment measurement

ADGRB3 NAV3 CDH5

4.11e-03442163EFO_0007998
DiseaseMalignant neoplasm of salivary gland

FAT1 VCAN CDH1

4.38e-03452163C0220636
Diseaseemphysema imaging measurement

NRG1 MYCBP2 HSP90AA4P IFT74 UNC13C

4.50e-031462165EFO_0007626
Diseasereticulocyte count

SEPTIN9 EML6 FAT1 KCNU1 PTPRJ RNF10 GMDS PLS1 FNDC3B ANK1 MED16 CCDC92 PRPF8 WDSUB1 CDH1 CDH5

4.54e-03104521616EFO_0007986
DiseaseSalivary Gland Neoplasms

FAT1 VCAN CDH1

4.95e-03472163C0036095
Diseaseage at onset, Myopia

ZSCAN12 DEF8 AP1M1 AKAP6 FLT1

5.04e-031502165EFO_0004847, HP_0000545
Diseaseobesity (implicated_via_orthology)

PCSK1 DCHS2 LPIN1 GNA11 FAT4 WDTC1

5.18e-032152166DOID:9970 (implicated_via_orthology)
DiseaseAutosomal recessive primary microcephaly

ZNF335 CDK5RAP2

5.26e-03152162cv:C3711387
Diseasesleep duration

ZSCAN12 MYCBP2 RAPGEF5 PTPRJ SCN1A CAMTA1 COG5 ANK1

5.42e-033622168EFO_0005271
DiseasePain, Crushing

NRG1 DISC1 AKT1

5.56e-03492163C0458259
DiseasePain, Splitting

NRG1 DISC1 AKT1

5.56e-03492163C0458257
DiseasePain

NRG1 DISC1 AKT1

5.56e-03492163C0030193
DiseasePain, Migratory

NRG1 DISC1 AKT1

5.56e-03492163C0751407
DiseaseSuffering, Physical

NRG1 DISC1 AKT1

5.56e-03492163C0751408
DiseaseRadiating pain

NRG1 DISC1 AKT1

5.56e-03492163C0234254
DiseasePain, Burning

NRG1 DISC1 AKT1

5.56e-03492163C0234230
DiseaseAche

NRG1 DISC1 AKT1

5.56e-03492163C0234238
DiseaseMammary Carcinoma, Human

NRG1 CENPF ADAM10 BMPR2 AKT1 NOS3 FLT1 SYNE1 CDH1 CDH5

5.57e-0352521610C4704874
DiseaseMammary Neoplasms, Human

NRG1 CENPF ADAM10 BMPR2 AKT1 NOS3 FLT1 SYNE1 CDH1 CDH5

5.57e-0352521610C1257931
Diseaseglaucoma

RAPGEF5 FMNL2 GMDS FNDC3B KALRN

5.62e-031542165MONDO_0005041
DiseaseMammary Neoplasms

NRG1 CENPF ADAM10 BMPR2 AKT1 NOS3 FLT1 SYNE1 CDH1 CDH5

5.72e-0352721610C1458155
Diseaseshigellosis

IL23R MPP7

5.98e-03162162EFO_0005585
DiseaseT-Cell Lymphoma

AKT1 ASXL3

5.98e-03162162C0079772
DiseasePre-Eclampsia

NOS3 FLT1

5.98e-03162162C0032914
Diseasenervousness

ETFDH PTPRJ

5.98e-03162162NCIT_C74532
Diseaseperiodontitis

MCM3AP CAMTA1 HSP90AA4P AKAP6 WDR36 FMNL3

6.17e-032232166EFO_0000649
Diseaseurate measurement, bone density

ADGRB3 VWA3B DNAH8 MPP7 AKAP6 SYNE1 CCDC92 MINPP1 THAP9 EYS PEAK1

6.19e-0361921611EFO_0003923, EFO_0004531
Diseaseepithelial cell adhesion molecule measurement

TPP2 EML6 PPP4R3B

6.22e-03512163EFO_0010574
Diseasefree cholesterol to total lipids in small HDL percentage

ETFDH ADAM10 SMARCA4

6.22e-03512163EFO_0022285
DiseaseAdenoid Cystic Carcinoma

ATRX FAT1 VCAN CDH1

6.33e-031002164C0010606
Diseasegastroesophageal reflux disease

SNRK NAV3 VCAN SORCS3

6.56e-031012164EFO_0003948
DiseaseBreast Carcinoma

NRG1 CENPF ADAM10 BMPR2 AKT1 NOS3 FLT1 SYNE1 CDH1 CDH5

6.58e-0353821610C0678222
Diseaselow density lipoprotein cholesterol measurement, body fat percentage

EFCAB13 CCDC92

6.75e-03172162EFO_0004611, EFO_0007800
Diseasemajor depressive disorder (is_marker_for)

NRG1 DISC1

6.75e-03172162DOID:1470 (is_marker_for)
DiseaseCannabis Dependence

NRG1 AKT1

6.75e-03172162C0006870
DiseaseKuhnt-Junius degeneration (is_implicated_in)

NOS3 FLT1

6.75e-03172162DOID:10873 (is_implicated_in)
DiseaseUremia

NOS3 FLT1

6.75e-03172162C0041948
DiseaseBell's palsy

DISC1 DNAH8 MGAT4C FNDC3B

6.79e-031022164EFO_0007167
Diseaseneutrophil percentage of granulocytes

SPEF2 PSMD3 SUOX WDR36 BATF RFX6

6.85e-032282166EFO_0007994

Protein segments in the cluster

PeptideGeneStartEntry
VTHTVQKVEAVQTSY

UMODL1

41

Q5DID0
ALYTHNKEVASAVSA

ACCSL

406

Q4AC99
AEITYTSKHSVEVQV

ACOT7

126

O00154
EIVSALDYLHSEKNV

AKT1

256

P31749
VSAEITYTSKHSVEV

ACOT7L

46

Q6ZUV0
EYTTEVHSKELTNVF

BDP1

2396

A6H8Y1
LNISYEINEVSVKHT

BBS7

591

Q8IWZ6
TEKESALATAQQYLH

AVIL

666

O75366
TNEEIAAYLITFEKH

CAMTA1

76

Q9Y6Y1
ETAIRALETYQSHKN

ELL2

36

O00472
HSKSVKVQERYDSAV

ANKRD10

396

Q9NXR5
ETTHEKIQAAEYGLV

BICD1

26

Q96G01
KEEVLQSTTGVSHYA

VCAN

456

P13611
TTKYDENITTVLLAH

VCAN

776

P13611
STGYQHQKVDIVSLE

B4GALNT2

276

Q8NHY0
DAYQVTDNLVLSIHK

ADGRB1

761

O14514
HYTTINVLDTEAKDA

ADGRB3

1481

O60242
EVAAYLTEKAHSVSV

AIFM3

346

Q96NN9
ISSHVKAIDTIYQTT

ADAM10

246

O14672
SATFEHLVYKINSNE

ADAM21

151

Q9UKJ8
DEHYLLATQSKQEQS

ACTR8

421

Q9H981
TASFVTYVVREHQTK

ABCA12

2001

Q86UK0
GSQEYEKVLVSVSEH

ANK1

1746

P16157
EITTKHNAELASYES

CCDC171

51

Q6TFL3
HLAIDSSNYEQESKI

GRM3

376

Q14832
SQATVHITVTEENYH

FAT4

3071

Q6V0I7
TDSKILQEYITQEGH

AP1M1

126

Q9BXS5
NKQVVEASYTAHLTS

CACHD1

106

Q5VU97
AIKADHVSTYAAFVQ

HLA-DPA1

31

P20036
ETTEKNQLFTIHYVS

GLCE

311

O94923
TTYITVLVKDTNDHS

CELSR1

336

Q9NYQ6
EDADTQSKVHQLYET

DCTN2

301

Q13561
HPVEVVYLSEAQKDS

DHX32

241

Q7L7V1
ENISEYHLTAVIVDK

CDH5

111

P33151
YHLTAVIVDKDTGEN

CDH5

116

P33151
LTDNHDNTANITVKY

CDH5

526

P33151
REVEHQETAYETSVK

DISC1

651

Q9NRI5
AIKTEHANYLNVSEL

ASXL3

1641

Q9C0F0
QDIYTHLVKSLQESD

CDK5RAP2

561

Q96SN8
EAKAETIQALYHQTL

MROH7

526

Q68CQ1
VNDTKHHLYSDINIT

NPFFR2

121

Q9Y5X5
DRLVTAKTESVQYDH

NOL12

86

Q9UGY1
SDAVKNESHVETTYL

RFX6

586

Q8HWS3
TQDALHTVEKYSFEE

IPP

496

Q9Y573
KTDAVEALTALNHYQ

HNRNPLL

506

Q8WVV9
IVSAHTQKTYEVNEV

GUF1

286

Q8N442
SKENIASVLENYHTE

HIBCH

236

Q6NVY1
QYVSKNVISSEHIVE

NRG1

311

Q02297
FVNASSKYEITTIHN

SERPIND1

186

P05546
TQRKEEESQSSSIYH

AOC2

631

O75106
VVEKSLDRETQSHYS

PCDH19

191

Q8TAB3
HLEYNVTVQENSAAK

FAT1

36

Q14517
QSSYEELKEISVVVH

MGAT4C

126

Q9UBM8
RVKLSVQTHSTDDYI

PTPRJ

1081

Q12913
EYQEAVSKSTFQHLV

IGDCC3

471

Q8IVU1
IIDSSRSVNTHDYAK

MATN2

61

O00339
VTLKTYSEITHANDF

EYS

1756

Q5T1H1
QSHVKISFDLAEYTA

GMDS

111

O60547
EQSVHQYTISKDEPL

NRAP

756

Q86VF7
KDITHSYLEQETTGI

MIPOL1

6

Q8TD10
ATYESVLFHQLQEIK

MTO1

611

Q9Y2Z2
YKIFVSIDEHTNVAE

FAM91A1

256

Q658Y4
QVDHAAAVKEYSRSS

MCM3AP

666

O60318
KHGVIISSTVDTYEN

F13B

531

P05160
TQHSYSEEEKVAFVN

PLS1

116

Q14651
KTTSVISHTYEEIET

PEAK1

656

Q9H792
DDVVLHVSSKTTLQY

NAV3

1121

Q8IVL0
VSDNINEVTFHAKDY

DNAH8

1611

Q96JB1
ADYISKNVPATDHVI

NRG2

471

O14511
ATANYSKAVHQVLDV

KALRN

496

O60229
ALLSVHDTVAQKNYD

MPP7

106

Q5T2T1
FYADDQSTHKQVLTL

MOSPD1

26

Q9UJG1
IQSYADQHKITIVDF

LRRC74A

416

Q0VAA2
ELVQEHAKTNISSYV

LPIN1

826

Q14693
LEVASDSYHKVASDV

LCT

426

P09848
HEYHAETIKNVRTAT

PKM

81

P14618
YEIVNKASQTTETHS

KCNU1

1056

A8MYU2
LHDASQDLVYETVAK

KIF9

61

Q9HAQ2
YQVFQKVTDHATTAL

MED27

236

Q6P2C8
KETEVLDSHIHAYVN

PTPRZ1

1996

P23471
EDIKSLTAHIVENFY

PPP4R3B

646

Q5MIZ7
EAEYVNSLASHKINV

DDX31

636

Q9H8H2
QYNTTIAHVTLDKDR

FOXRED2

141

Q8IWF2
AQTYHLKASSEVERQ

OSBP

156

P22059
NVEKTLSCLDHVISY

EXOC7

76

Q9UPT5
VTVHQSIGEAKEQFY

MDGA2

136

Q7Z553
VEHASEKLQLVISYT

MFN2

666

O95140
KHENIVTLEDIYEST

CAMK1G

76

Q96NX5
QSLVEKLHEEYTRQT

MED16

501

Q9Y2X0
DKAAVEINVAVLHSY

NOS3

396

P29474
SHAEIIYNIISGNEK

DCHS2

2696

Q6V1P9
ADNQVVYLHKITDSV

HFM1

1036

A2PYH4
KTYTSQSIHQAVIAE

COG5

76

Q9UP83
FQELDEHISYVATKV

EXOC5

96

O00471
ENLQSKTIGLHVTEY

ETFDH

421

Q16134
DTDINEIHTNHKTLY

ATRX

751

P46100
ATETHLNIYGQEAKV

CDHR2

321

Q9BYE9
YEALKTQLQENETHS

IFT74

526

Q96LB3
EVIFAVYHENTKSAS

C2CD3

1291

Q4AC94
VYHENTKSASDIISI

C2CD3

1296

Q4AC94
IKSYSIEDHIIKSNT

E2F8

221

A0AVK6
SKDYIVALQHPVTTD

GNE

211

Q9Y223
ESNSYEHLTLSDKEV

CENPF

1386

P49454
KENEVSEHTLESYRS

CRTAM

321

O95727
QQHCTDLTYELTVKS

CCDC92

56

Q53HC0
ENVTVPASAHKIEYS

FRS2

396

Q8WU20
SNSKTHAAEDIVYTL

FNDC3B

981

Q53EP0
AHYDAVEAELKSSTV

FAM50A

51

Q14320
ELESIKETYENTSHQ

FMNL3

436

Q8IVF7
TEELKYFTSVLNSHE

BATF

76

Q16520
VDVEKVTTFEHQYVS

GNA11

116

P29992
VTTFEHQYVSAIKTL

GNA11

121

P29992
VTSEFESYKVRVHNV

GCC2

1316

Q8IWJ2
HVKSLETEEEQQYLT

IL23R

161

Q5VWK5
YIEDSIHHTDSIVKN

BMPR2

551

Q13873
KNLDYVATSIHEAVT

GOT1

396

P17174
EVISTLHYFSKVVDE

APPL2

81

Q8NEU8
HYVEKAAAVSLENVL

FMNL2

886

Q96PY5
EEAAHTLTISIYDTK

DRC7

706

Q8IY82
EILEEVTKHTYIDSN

EFCAB13

256

Q8IY85
VSSKVSHQAEYELNI

DEF8

251

Q6ZN54
EYSVHKITSTFHQDV

LAMC2

201

Q13753
DSYTVQTISVLKDVH

EML5

91

Q05BV3
DSYNVQTVSLLKDVH

EML6

91

Q6ZMW3
QHITLSDEERKIYQS

HLTF

666

Q14527
AYSVAEKVTVITKHN

HSP90AA4P

81

Q58FG1
VSERYAHQQETSSKV

CCDC168

5756

Q8NDH2
YDILAFAKESVNSHV

DNAJC10

441

Q8IXB1
VTYHVNIVLEEESTK

SACS

371

Q9NZJ4
TEHVVSIVTDYHNLK

DSEL

711

Q8IZU8
INEDSKDITAYHTVF

FAM171B

341

Q6P995
KNLSYEAAPSHEVVV

CDH16

516

O75309
EDFEHVKNSTYTALI

CDH1

551

P12830
SHEESELANKLITVY

CEBPZ

451

Q03701
KYEHDDIVSTVSVLS

WDR77

121

Q9BQA1
KIEISTIASNYHLEV

RFC3

81

P40938
LIYASVSVHAAKQEE

APOOL

16

Q6UXV4
EEESVHVTQRKTHYS

ORC3

166

Q9UBD5
QHEETTYIAIALKSS

NRK

1321

Q7Z2Y5
AVTVHYIADKNATAT

NRAC

76

Q8N912
TLKEIQEASTIVYEH

FREM3

1256

P0C091
TDLKHYSDELQSVIS

SNX4

221

O95219
TDVARYHIETSTKIQ

SPEF2

1411

Q9C093
AARTKTYVQEHSVVD

PRELID3B

71

Q9Y3B1
KTTVYVSHINDLSDF

TDRD6

1306

O60522
REYLSEEVQAVHKNT

USP39

481

Q53GS9
EEVQAVHKNTTYDLI

USP39

486

Q53GS9
SLLEDTTSAYQEHEK

SYNE1

4771

Q8NF91
ETKSVTEVDTLALHY

TMEM161B

86

Q8NDZ6
KVSDSISAQYPVVDH

SDHA

46

P31040
LTEESYESKQSHEVL

TDRD9

1086

Q8NDG6
YQDSTIKDLSHEVTR

FER1L5

481

A0AVI2
VHVVISSDSLADKNY

HPS3

841

Q969F9
YLEDVAKNETSATHQ

LMBRD2

336

Q68DH5
TKEIAVHEYFQSQLL

SORCS3

991

Q9UPU3
VTQEDAGSYTLHIIK

PSG6

111

Q00889
QTITEYDEHLTQLEK

TAF1L

1621

Q8IZX4
QEAEHITSVYLQLKA

ODAD3

221

A5D8V7
TSDYVTVHSDVERKK

OVCH2

486

Q7RTZ1
NQTVVVEYTHDKDTD

PELI2

86

Q9HAT8
HIANELLQTEKAYVS

FGD1

376

P98174
TQRHSAVQTKEQYEL

PTPN12

271

Q05209
SCIYVNKITHEVDEL

POLR2I

51

P36954
TKAVATYHANTEREQ

SMARCA4

501

P51532
QNIKDITSSIHFEAY

SEPTIN9

546

Q9UHD8
EHSYVSVKAKVSSIA

RAPGEF5

251

Q92565
VQVKAAFNEETHSYE

SETD4

241

Q9NVD3
TLTIHNVEKQDIATY

TRGV9

101

Q99603
ENRITKTVSHLYQES

TANC1

1816

Q9C0D5
YKQESSESHNIVITE

SEMG2

546

Q02383
TITVQTKDQYGDVVH

MYCBP2

2286

O75592
DEYLINSQTTEHIVK

IARS2

541

Q9NSE4
DIVNKEDIYSHLTSV

MROH2B

26

Q7Z745
SYKNLSEEEHNSIIQ

SNRK

286

Q9NRH2
TVYSIFSKVHSDRNV

SGCE

36

O43556
HIVKTVDFTQDSNYL

STRAP

101

Q9Y3F4
KGVQIHTSVVDSDYK

ERVK-9

711

P63128
HTSVVDSDYKGEIQL

ERVK-9

716

P63128
SLEEHSIEKNITVNY

SCN1A

286

P35498
VEDYAETVHQLSKTS

SPTBN1

1641

Q01082
EAAHSEILKYFQSVT

STX5

316

Q13190
SAINFHSVVEKYVSE

TASOR

546

Q9UK61
HVASTVQTYSAIEEA

ABTB1

446

Q969K4
DLTYSVQQDSDSKHV

AKAP6

86

Q13023
ERQSPVDIDTHTAKY

CA2

26

P00918
ATETVSHKALDADIY

C12orf29

36

Q8N999
TDEIRQSDYITEKHS

C12orf40

251

Q86WS4
EVKHVHLENATEYAT

C11orf52

91

Q96A22
DDTNVYRVTIHKTFE

PRPF8

1781

Q6P2Q9
RTNHIYVSSDDIKET

PRPF8

2086

Q6P2Q9
ENSKHSEVLIDLTEY

WDTC1

166

Q8N5D0
DYKTVIFENLSQHIA

ZNF639

266

Q9UID6
VIEASINHEKGYVQS

PSMD3

446

O43242
ESDILEKQTTTHYAD

UNC13C

516

Q8NB66
SLYHVESTVNSELKA

MIOS

26

Q9NXC5
LTEVEKNATALYHVE

MINPP1

236

Q9UNW1
SNKNASEHIVYLLEV

RLF

86

Q13129
TVIYKNQDLSQATDH

SPEM3

816

A0A1B0GUW6
SHSDYVIDDKVAVLQ

SHANK3

561

Q9BYB0
SQEVATEDHNYSLKT

THAP9

116

Q9H5L6
VSEDSSVTQIYHAVA

RPN2

116

P04844
TYIAKVDGEISASHV

ROPN1

166

Q9HAT0
KSVVATESHQYVVGD

RNF10

276

Q8N5U6
DHTEEVSNLVNYVLK

SUN3

161

Q8TAQ9
SEENVKIIENHFTTY

THAP5

376

Q7Z6K1
VVKSAQHYTETALDE

SRPK2

111

P78362
ITAVIAAKVNESSHY

TPP2

631

P29144
TEYVKTQLQLDERSH

SLC25A1

46

P53007
SGYVKSLAVHVAETE

NUP188

1076

Q5SRE5
AIETLIKNFHQYSVE

S100A14

21

Q9HCY8
TVNGHLDSYEKVTQL

SOCS3

196

O14543
QVTENTTEKAATYHV

SERPINB4

61

P48594
VDLYQEVSLSHKDNI

SERPINI2

31

O75830
YEHTINKDTTHLEIE

POLR3B

646

Q9NW08
ASEIEDHIYQELKST

TCEA3

216

O75764
VATEDDFYTSHNLVK

PKHD1L1

3946

Q86WI1
SEKYNHAITEVINTV

SMCO3

206

A2RU48
KVYTDVQQVASSLTH

TTLL12

306

Q14166
KQSETSIHQYLVDEP

STRADB

21

Q9C0K7
AVTNLYKESVDTHQR

TAPR1

96

Q14CZ0
RAAQESTHIYTKEEV

SUOX

76

P51687
ERESVESLIQKHSYA

TBX20

296

Q9UMR3
VKHYLEQHEETSAAV

ZNF142

1396

P52746
KSELIYQFVEHLTQA

VWA3B

101

Q502W6
KSVIVYDTNTENILH

WDSUB1

261

Q8N9V3
VDSTDRVYFVNHNTK

WWP1

466

Q9H0M0
SVNTSVHIYDKAFIT

FLT1

321

P17948
AVVVSDTLKEAGTHY

ZNF335

911

Q9H4Z2
KAFVYNSSLVSHQEI

ZSCAN12

421

O43309
ISAEKAYHEQLTVAE

TUBA1C

276

Q9BQE3
YQTSQERVVDKHESV

USP6

1006

P35125
TAYIHQVTVQKEALS

ZNF76

41

P36508
VALEQYASKVLHDSQ

ZNF76

136

P36508
HFESKLSDTIEVYQE

VWA3A

136

A6NCI4
FHTYDVQKLSLVAVS

WDR36

106

Q8NI36
AHYDAVEAELKSSTV

FAM50B

51

Q9Y247
IKSLEHVQFEATIEY

PCSK1

501

P29120